We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B Turnover 27.25%
1-Year Est. Return 31.07%
 

Two Sigma Advisers is the investment manager behind a small set of Two Sigma hedge funds, including Two Sigma Absolute Return Cayman Fund, Two Sigma Absolute Return Fund and Two Sigma Strategies Allocator Fund. Revocable trusts of David Siegel and John Overdeck, who founded the investment and trading firm Two Sigma Investments in 2001, are among its limited partners.

This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.06%
AUM
$51.4B
AUM Growth
+$1.46B
Cap. Flow
+$988M
Cap. Flow %
1.92%
Top 10 Hldgs %
18.85%
Holding
2,686
New
375
Increased
1,038
Reduced
898
Closed
357
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$512M
2
AMD icon
Advanced Micro Devices
AMD
+$401M
3
RBLX icon
Roblox
RBLX
+$384M
4
TSM icon
TSMC
TSM
+$371M
5
TJX icon
TJX Companies
TJX
+$271M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Consumer Discretionary 14.54%
3 Financials 14.39%
4 Healthcare 12.45%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VNO icon
1651
Vornado Realty Trust
VNO
$6.38B
$712K ﹤0.01%
+21,400
New +$782K
2025 Q4
0 quarters
CCO icon
1652
DELISTED
Clear Channel Outdoor Holdings
CCO
$709K ﹤0.01%
320,715
+112,300
+54% +$208K
2020 Q3
21 quarters
HR icon
1653
Healthcare Realty
HR
$6.5B
$709K ﹤0.01%
+41,800
New +$744K
2025 Q4
0 quarters
KMDA icon
1654
Kamada
KMDA
$478M
$704K ﹤0.01%
99,700
+4,400
+5% +$30.4K
2025 Q1
3 quarters
GOTU icon
1655
Gaotu Techedu
GOTU
$562M
$702K ﹤0.01%
302,600
+29,500
+11% +$79.9K
2024 Q4
4 quarters
VMD icon
1656
Viemed Healthcare
VMD
$351M
$698K ﹤0.01%
94,000
+19,200
+26% +$132K
2022 Q3
13 quarters
ALRS icon
1657
Alerus Financial
ALRS
$835M
$698K ﹤0.01%
31,000
-9,100
-23% -$198K
2021 Q3
17 quarters
RGNX icon
1658
Regenxbio
RGNX
$479M
$697K ﹤0.01%
48,400
-21,700
-31% -$270K
2023 Q4
8 quarters
CVGI icon
1659
Commercial Vehicle Group
CVGI
$136M
$695K ﹤0.01%
482,300
-72,600
-13% -$115K
2015 Q4
40 quarters
RIGL icon
1660
Rigel Pharmaceuticals
RIGL
$807M
$694K ﹤0.01%
16,198
+7,870
+95% +$297K
2013 Q4
48 quarters
WEAV icon
1661
DELISTED
Weave Communications
WEAV
$691K ﹤0.01%
91,000
-26,800
-23% -$178K
2023 Q2
10 quarters
CNXC icon
1662
Concentrix
CNXC
$1.86B
$690K ﹤0.01%
+16,600
New +$674K
2025 Q4
0 quarters
PRLD icon
1663
Prelude Therapeutics
PRLD
$266M
$688K ﹤0.01%
237,300
+14,600
+7% +$24.6K
2021 Q4
16 quarters
LYTS icon
1664
LSI Industries
LYTS
$571M
$685K ﹤0.01%
37,400
+11,400
+44% +$232K
2025 Q2
2 quarters
CCNE icon
1665
CNB Financial
CCNE
$1.02B
$681K ﹤0.01%
26,037
-34,300
-57% -$870K
2019 Q4
24 quarters
CNNE icon
1666
Cannae Holdings
CNNE
$669M
$681K ﹤0.01%
43,300
-2,000
-4% -$34K
2024 Q4
4 quarters
LDI icon
1667
loanDepot
LDI
$238M
$680K ﹤0.01%
+328,500
New +$912K
2025 Q4
0 quarters
BELFB icon
1668
Bel Fuse Class B
BELFB
$3.2B
$679K ﹤0.01%
4,000
-1,738
-30% -$272K
2019 Q4
24 quarters
ACIC icon
1669
American Coastal Insurance
ACIC
$474M
$678K ﹤0.01%
53,700
-5,500
-9% -$66.4K
2019 Q4
24 quarters
HRTX icon
1670
Heron Therapeutics
HRTX
$52.3M
$675K ﹤0.01%
519,571
+337,500
+185% +$417K
2022 Q3
13 quarters
JBGS icon
1671
JBG SMITH
JBGS
$687M
$662K ﹤0.01%
+38,900
New +$735K
2025 Q4
0 quarters
PLXS icon
1672
Plexus
PLXS
$5.58B
$662K ﹤0.01%
+4,500
New +$660K
2025 Q4
0 quarters
MLR icon
1673
Miller Industries
MLR
$535M
$661K ﹤0.01%
17,700
-4,500
-20% -$175K
2016 Q4
36 quarters
KPTI icon
1674
DELISTED
Karyopharm Therapeutics
KPTI
$660K ﹤0.01%
+89,729
New +$549K
2025 Q4
0 quarters
UNFI icon
1675
United Natural Foods
UNFI
$3.09B
$660K ﹤0.01%
19,600
-3,700
-16% -$138K
2025 Q3
1 quarter

Similar funds

Two Sigma Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Two Sigma Advisers held 2,686 positions worth $51.4B, up 2.9% from $50B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Two Sigma Advisers's Q4 2025 filing shows 375 new, 1,038 increased, 898 reduced and 357 closed positions. Its largest new stake was Kimberly-Clark: 2,442,100 shares worth $246M. The largest sale was Bank of America, an estimated $569M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Two Sigma Advisers's largest Q4 2025 buy was Kimberly-Clark: 2,442,100 shares worth $246M.
  • Two Sigma Advisers added most to ServiceNow in Q4 2025, an estimated $512M increase.
  • Two Sigma Advisers's biggest Q4 2025 reduction was Bank of America, cutting an estimated $569M.
  • Two Sigma Advisers fully exited Nebius Group in Q4 2025, selling an estimated $257M.
  • Two Sigma Advisers's ten largest holdings make up 19% of its $51.4B portfolio in Q4 2025.
  • Two Sigma Advisers opened 375 new positions and closed 357 in Q4 2025.
  • Two Sigma Advisers's portfolio value rose 2.9% quarter-over-quarter to $51.4B.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.